Although further investigations are warranted to fully elucidate the synergistic effect of IL-1RA on liver fibrosis and the NLRP3-inflammasome mechanism, the results of this study establish the therapeutic potential of C-192 for the treatment of fibrosis. The gene discussed is NLRP3; the disease is fibrosis.